United States: Offering Ridesharing Services To Patients: Uber Risky?

Last Updated: November 9 2016
Article by Erica C. Mallon and Elizabeth Scarola

More than three million Americans miss or delay medical appointments every year because of inadequate transportation,1and ridesharing companies are eager to break into the $3 billion industry.2

Several ridesharing companies are providing non-emergency medical transportation (NEMT) services in cities across the country. As traditional public transit and taxi cab services can be fraught with cancellations, delays, and lengthy travel time, ridesharing platforms appear to offer promising solutions to access and continuity of care issues, particularly for vulnerable patient populations with limited resources. Just as ridesharing companies have aimed to fill a need in the market for general transportation, they see a need to be met in the NEMT space as well.

Uber is the most recent ridesharing company to announce a NEMT initiative through a partnership with Circulation, a Boston-based startup, that intends to pilot a NEMT digital service initiative at three hospital locations on the East Coast, as well as an all-inclusive care program for the elderly.3 Circulation's Health Insurance Portability and Accountability Act4- (HIPAA-) compliant platform integrates with existing hospital electronic medical records systems to pull patient contact information and medical history, allowing for verification of health insurance and ride eligibility, as well as auto-population of specific transportation needs (i.e., wheelchair assistance, hearing/vision impairment, or necessity to travel with a caregiver).

Circulation allows hospital transportation coordinators to schedule and manage rides to/from authorized sites (as determined by the hospital), restricting pick-up and drop-off locations in an effort to protect against system abuse. The hospital arranging for the ride pays the bill, but Circulation platform provides monthly expense reports and billing invoices to participating hospitals and each hospital may decide to sponsor rides for their patients, share ride costs with their patients, and/or submit claims for reimbursement, as appropriate.

Separate from its partnership with Circulation, Uber already offers NEMT services via unique partnerships with various hospitals across the country. Other ridesharing companies in the NEMT space include Lyft and Veyo. In January, Lyft, began offering NEMT services via the National Medtrans Network in New York and CareMore in California.5 San Diego-based startup Veyo plans to offer NEMT services for Medicaid patients in Idaho.6

The benefits, however, should be considered in light of the various legal and regulatory risks the services pose including licensing, insurance, fraud and abuse, privacy, and reimbursement issues.

Licensing and Insurance

Providers should consider the legality of the platform itself, along with the potential risk of liability arising from driver negligence. Horrific news stories about violent or inappropriate drivers pop up with some consistency, and providers could find themselves entangled in a public relations and legal nightmare if they arrange for service with such a driver. Ridesharing companies often face intense scrutiny for licensing,7 insurance,8 and even discrimination9 issues, which can become provider issues if providers are arranging patient transportation services through these ridesharing companies. Providers should avoid joint-marketing initiatives with ridesharing companies to ensure a clear distinction between the transportation service and the provider's medical services. Providers also may wish to avoid an exclusive relationship with any one ridesharing company to decrease a patient's perception that the NEMT ridesharing company is an agent of the provider.

Fraud and Abuse

Ridesharing initiatives pose fraud and abuse concerns if providers offer these services at little or no cost to federal program beneficiaries. Potential violations of the Civil Monetary Penalties Law,10 the federal Anti-Kickback Statute,11 and Stark Law12 can lead to severe penalties.13

The Department of Health and Human Services Office of Inspector General (OIG) has issued several Advisory Opinions acknowledging that "free transportation arrangements have . . . beneficial effects on patient care, especially where such arrangements are narrowly tailored to address issues of financial need, limited transportation resources, treatment compliance, or safety."14

To meet the favorable treatment of past OIG Advisory Opinions, providers must bear the total cost for the free transportation service and cannot shift such cost to any federal health care program, payer, or individual. The free transportation service should:

  • be provided only to established patients for medically necessary services;15
  • not target select profitable patient populations;16
  • not be marketed or advertised;17
  • not be provided via luxury transportation;18
  • not be provided outside of a provider's geographic service area (25 miles)19; and
  • not be of a greater value than $10 per trip or $50 per year per beneficiary.20
  • Of note, transportation to and from an offeror's premises presents a lower risk than transportation to a different provider or supplier.


As with any arrangement, providers must consider HIPAA-associated privacy implications. Providers should consider the patient protected health information (PHI) that ridesharing companies may store including patient names, addresses, and phone numbers. Even if a platform is HIPAA-compliant, providers risk potential imposition of stiff penalties for data breaches, and Business Associate Agreements should be implemented between providers and ridesharing companies.


With many, if not all, ridesharing NEMT programs, the provider pays the cost of transportation upfront and then determines whether to bill for it later. Providers seeking reimbursement should consider whether payers will reimburse for NEMT. Medicaid covers qualified NEMT, with the extent of reimbursement varying by state. Although traditional Medicare does not cover NEMT, commercial Medicare Advantage plans cover NEMT for nearly 70% of beneficiaries.21 Private payer coverage will vary by contract.


For now, participating providers offering NEMT services face the lowest risk if such services are solely offered to established patients with financial need, without access to adequate transportation, who require frequent appointments for high-risk medical needs. If in doubt, providers may always seek advice from experienced legal counsel on proposed arrangements.


1 Richard Wallace et al., Access to Health Care and Nonemergency Medical Transportation: Two Missing Links, Transportation Research Record Journal of the Transportation Research Board, at 76 (Jan. 2005).

2 Richard Garrity and Kathy McGehee, Impact of the Affordable Care Act on Non-Emergency Medical Transportation (NEMT): Assessment for Transit Agencies, 2 (2014).

3 Circulation Chosen as Uber's Preferred Healthcare Platform Partner for Non-Emergency Medical Transportation; Launches Hospital Pilot Programs, BusinessWire, Sept. 27, 2016, available at http://www.businesswire.com/news/home/20160927005396/en/Circulation-Chosen-Uber%E2%80%99s-Preferred-Healthcare-Platform-Partner.

4 Pub. Law No. 104-191.

5 Meg Bryant, Rideshare Partnerships Could Help Lower Costs of Patient Transport, HealthcareDIVE, Sept. 7, 2016,available at http://www.healthcaredive.com/news/rideshare-partnerships-could-help-lower-costs-of-patienttransport/ 425808.

6 Audrey Dutton, Can Uber-style rides work for Medicaid patients in Idaho?, July 13, 2016, available at http://www.idahostatesman.com/news/local/watchdog/article89518017.html.

7 Thompson Reuters, Michigan Attacks May Renew Scrutiny of Uber Vetting Processes, Bus. Ins., Feb. 23, 2016, available at, http://www.businessinsurance.com/article/20160223/NEWS06/160229950.

8 Jason Williams, Uber, Lyft Arrive Amid Praise, Scrutiny, Cincinnati Enquirer, Apr. 10, 2014, available at http://www.cincinnati.com/story/news/2014/04/09/uber-lyft-raising-questionssafety- fairness/7506935.

9 Dan Adams, New Law Says Uber, Lyft Must be Accessible to All, Boston Globe, Aug. 11, 2016, available at https://www.bostonglobe.com/business/2016/08/11/under-new-law-uber-and-lyftmust-accessible-all/gJ5E4Xvpf60A5la8Ad95HL/story.html..

10 42 U.S.C. § 1320a–7a.

11 42 U.S.C. § 1320a-7b.

12 42 U.S.C. § 1395nn. Note that a Stark Law implication will depend on whether a financial relationship exists between the transportation provider and the location to which the provider sends the beneficiary.

13 John Carreyrou, Florida Hospitals Agree to Settle Medicare-Fraud Allegations, Wall St. J., Apr.30, 2015 (Nine Jacksonville hospitals and an ambulance company paid $7.5 million to settleallegations of beneficiary inducement and improper Medicare billing for NEMT services), availableat http://www.wsj.com/articles/florida-hospitals-agree-to-settle-medicare-fraud-allegations-1430419940.

14 OIG Advisory Opinion no. No. 00-7 (Nov. 24, 2000).

15 OIG Advisory Opinion no. 16-02 (Mar. 1, 2016); OIG Advisory Opinion no. 15-13 (Oct. 21,2015); OIG Advisory Opinion no. 11-02 (Mar. 24, 2011); OIG Advisory Opinion no. 11-01 (Jan. 10,2011); OIG Advisory Opinion no. 09-01 (Mar. 13, 2009).

16 OIG Advisory Opinion no. 16-02 (Mar. 1, 2016); OIG Advisory Opinion no. 15-13 (Oct. 21,2015); OIG Advisory Opinion no. 13-04 (June 14, 2013); OIG Advisory Opinion no. 11-02 (Mar. 24,2011); OIG Advisory Opinion no. 11-01 (Jan. 10, 2011);OIG Advisory Opinion no. 09-01 (Mar. 13,2009); OIG Advisory Opinion no. 00-7 (Nov. 24, 2000).

17 OIG Advisory Opinion no. 16-02 (Mar. 1, 2016); OIG Advisory Opinion no. 15-13 (Oct. 21,2015); OIG Advisory Opinion no. 13-04 (June 14, 2013); OIG Advisory Opinion no. 11-01 (Jan. 10,2011); OIG Advisory Opinion no. 09-01 (Mar. 13, 2009).

18 OIG Advisory Opinion no. 16-02 (Mar. 1, 2016); OIG Advisory Opinion no. 15-13 (Oct. 21,2015).

19 OIG Advisory Opinion no. 15-13 (Oct. 21, 2015); OIG Advisory Opinion no. 13-04 (June 14,2013); OIG Advisory Opinion no. 00-7 (Nov. 24, 2000).

20 OIG Advisory Opinion no. 11-02 (Mar. 24, 2011); OIG Advisory Opinion no. 09-01 (Mar. 13,2009); OIG Advisory Opinion no. 00-7 (Nov. 24, 2000).

21 Bryant, supra note 5.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions